Your browser doesn't support javascript.
loading
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva, Olga A; Maksoud, Rebekah; Beeraka, Narasimha M; Madhunapantula, SabbaRao V; Sinelnikov, Mikhail; Nikolenko, Vladimir N; Neganova, Margarita E; Klochkov, Sergey G; Amjad Kamal, Mohammad; Staines, Donald R; Marshall-Gradisnik, Sonya.
Afiliação
  • Sukocheva OA; College of Nursing and Health Sciences, Flinders University of South Australia, Bedford Park 5042, SA, Australia; The National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia. Electronic address: olga.sukocheva@fl
  • Maksoud R; The National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia; Consortium Health International for Myalgic Encephalomyelitis, National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coa
  • Beeraka NM; Department of Biochemistry, Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR), JSS Academy of Higher Education & Research (JSS AHER), Mysore, India.
  • Madhunapantula SV; Department of Biochemistry, Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR), JSS Academy of Higher Education & Research (JSS AHER), Mysore, India; Special Interest Group in Cancer Biology and Cancer Stem Cells (SIG-CBCSC), JSS Medical College, JSS Academy of Higher Edu
  • Sinelnikov M; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Mohovaya 11c10, Moscow, Russia.
  • Nikolenko VN; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Mohovaya 11c10, Moscow, Russia.
  • Neganova ME; Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka 142432, Russia.
  • Klochkov SG; Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka 142432, Russia.
  • Amjad Kamal M; King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia; Enzymoics, 7 Peterlee Place, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia.
  • Staines DR; The National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia; Consortium Health International for Myalgic Encephalomyelitis, National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coa
  • Marshall-Gradisnik S; The National Centre for Neuroimmunology and Emerging Diseases, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia; Consortium Health International for Myalgic Encephalomyelitis, National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coa
J Adv Res ; 40: 179-196, 2022 09.
Article em En | MEDLINE | ID: mdl-36100326
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica / COVID-19 Limite: Humans Idioma: En Revista: J Adv Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica / COVID-19 Limite: Humans Idioma: En Revista: J Adv Res Ano de publicação: 2022 Tipo de documento: Article